Table 2.
Relative sensitivity profile of Escherichia coli and Staphylococcus aureus compared to the orally administered group of antimicrobial drugs safe for use during pregnancy.
| Antimicrobial agents | S |
R/I |
n | Duration of treatment |
|---|---|---|---|---|
| n (%) | ||||
| Escherichia coli | ||||
| Cephalexin | 93.3 | 6.7 | 15 | 10 days |
| Fosfomycin | 90.9 | 9.1 | 88 | Single dose |
| Cefadroxil | 88.9 | 11.1 | 27 | 3 days |
| Amoxicillin/clavulanic acid | 80.0 | 20.0 | 5 | 7–10 days |
| Ampicillin | 64.9 | 35.1 | 37 | 7–14 days |
| Amoxicillin | 13.6 | 86.4 | 22 | 7–10 days |
| Staphylococcus aureus | ||||
| Cefadroxil | 100.0 | 0 | 6 | 3 days |
| Cephalexin | 100.0 | 0 | 2 | 10 days |
| Fosfomycin | 84.2 | 15.8 | 19 | Single dose |
| Ampicillin | 83.3 | 16.7 | 6 | 7–14 days |
| Amoxicillin | 7.1 | 92.9 | 14 | 7–10 days |
| Amoxicillin/clavulanic acid | NA | NA | – | 7–10 days |
S, sensitive; R/I, resistant or intermediate.